Abbott, Andrew. The System of Professions: An Essay on the Division of Expert Labor. Chicago: University of Chicago Press, 1988.
Abramson, Harold A. “LSD as an Adjunct to Psychotherapy with Elimination of Fear of Homosexuality.” Journal of Psychology 39 (1955): 127–55.
Abramson, Harold A., ed. The Use of LSD in Psychotherapy and Alcoholism. Indianapolis: Bobbs-Merrill, 1967.
Abramson, Harold A., ed. The Use of LSD in Psychotherapy: Transactions of a Conference on d-Lysergic Acid Diethylamide (LSD-25). New York: Josiah Macy Foundation, 1960.
Alpert, Richard, and Sidney Cohen. LSD. New York: New American Library, 1966.
Altman, Lawrence K. Who Goes First? The Story of Self-Experimentation in Medicine. Berkeley: University of California Press, 1987.
American Psychiatric Association. “Position Statement on LSD.” American Journal of Psychiatry 123 (1966): 353.
Anderson, Brian, Alicia Danforth, Robert Daroff, Christopher Stauffer, James Dilley, Jennifer Mitchell, and Joshua Woolley. “Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Surivors.” Biological Psychiatry 85 (2019): 182.
Anderson, Erik Murray L. “‘Safe from Utopia?’ The LSD Controversy in Saskatchewan, 1950–1967.” MA thesis, University of British Columbia, Vancouver, 1996.
Azocar, Maria J., and Myra Marx Ferree. “Gendered Expertise.” Gender and Society 29 (2015): 841–62.
Ball, J. R., and Jean J. Armstrong. “The Use of LSD-25 in the Treatment of the Sexual Perversions.” Canadian Journal of Psychiatry 6 (1961): 231–35.
Barnett, B. S., W. O. Sui, and H. G. Pope. “A Survey of American Psychiatrists’ Attitudes toward Classic Hallucinogens.” Journal of Nervous and Mental Disease 206 (2018): 476–80.
Barrett, Frederick S., Matthew W. Johnson, and Roland Griffiths. “Validation of the Revised Mystical Experience Questionnaire in Experimental Sessions with Psilocybin.” Journal of Psychopharmacology 29 (2015): 1182–90.
Barron, Frank, and Timothy Leary. “Changes in Psychoneurotic Patients with and without Psychotherapy.” Journal of Consulting Psychology 19 (1955): 239–45.
Beecher, Henry K. “Psychotomimetic Drugs.” Journal of Chronic Diseases 8 (1958): 253–85.
Beecher, Henry K. “Science, Drugs, Students.” Harvard Alumni Bulletin 65 (1963): 338.
Belser, Alexander B., Gabrielle Agin-Liebes, T. Cody Swift, Sara Terrana, Neşe Devenot, Harris L. Friedman, Jeffrey Guss, Anthony Bossis, and Stephen Ross. “Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretive Phenomenological Analysis.” Journal of Humanistic Psychology 57 (2017): 354–88.
Bisbee, Cynthia, Paul Bisbee, Erika Dyck, Patrick Farell, James Sexton, and James W. Spisak. Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond. Kingston, Ontario: McGill–Queen’s Press, 2018.
Blewett, Duncan B. The Frontiers of Being. New York: Award Books, 1969.
Blewett, Duncan, and N. Chwelos. Handbook for the Therapeutic Use of LSD-25. Pamphlet, 1959.
Blum, Richard. Utopiates: The Use and Users of LSD 25. New York: Atherton Press, 1964.
Bogenschutz, Michael O., Alyssa A. Forcehimes, Jessica A. Pommy, Claire E. Wilcox, P. C. R. Barbosa, and Rick J. Strassman. “Psilocybin-Assisted Treatment for Alcohol Dependence: A Proof-of-Concept Study.” Journal of Psychopharmacology 29 (2015): 289–99.
Braden, William. “LSD and the Press.” In Psychedelics: The Uses and Implications of Hallucinogenic Drugs, edited by Bernard Aaronson and Humphrey Osmond, 400–17. New York: Anchor Books, 1969.
Bravo, Gary, and Charles Grob. “Shamans, Sacraments, and Psychiatrists.” Journal of Psychoactive Drugs 21 (1989): 123–28.
Brown, Jay David, and Louise Reitman. “Psilocybin Studies and the Religious Experience: An Interview with Roland Griffiths.” MAPS Bulletin 20 (2010): 22–25.
Buckman, John. “Lysergic Acid Diethylamide.” British Medical Journal 2 (1966): 302–3.
Busch, Anthony K., and Warren C. Johnson. “LSD 25 as an Aid in Psychotherapy.” Diseases of the Nervous System 11 (1950): 241–43.
Campbell, Nancy D. Discovering Addiction: The Science and Politics of Substance Abuse Research. Ann Arbor: University of Michigan Press, 2007.
Carbonaro, Theresa M., Matthew P. Bradstreet, Frederick S. Barrett, Katherine A. MacLean, Robert Jesse, Matthew W. Johnson, and Roland R. Griffiths. “Survey Study of Challenging Experiences after Ingesting Psilocybin Mushrooms: Acute and Enduring Positive and Negative Consequences.” Journal of Psychopharmacology 30 (2016): 1268–78.
Carhart-Harris, Robin L., Mark Bolstridge, James Rucker, Camilla M. J. Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A. Rickard, Ben Forbes, Amanda Feilding, David Taylor, Steve Pilling, Valerie H. Curran, and David J. Nutt. “Psilocybin with Psychological Support for Treatment-Resistant Depression.” Lancet Psychiatry 3 (2016): 619–27.
Carhart-Harris, Robin L., David Erritzoe, Tim Williams, James M. Stone, Laurence J. Reed, Alessandro Colasanti, Robin J. Tyacke, Robert Leech, Andrea L. Malizia, Kevin Murphy, Peter Hobden, John Evans, Amanda Feilding, Richard G. Wise, and David J. Nutt. “Neural Correlates of the Psychedelic State as Determined by fMRI Studies with Psilocybin.” Proceedings of the National Academy of Sciences of the United States of America 109 (2012): 2138–43.
Carhart-Harris, Robin L., Mendel Kaelen, Mark Bolstridge, Tina Williams, Luke T. J. Williams, Raphael Underwood, Amanda Feilding, and David J. Nutt. “The Paradoxical Psychological Effects of Lysergic Acid Diethylamide.” Psychological Medicine 46 (2016): 1379–90.
Carhart-Harris, Robin L., Robert Leech, Peter J. Hellyer, Murray Shanahan, Amanda Feilding, Enzo Tagliazucch, Dante R. Chialvo, and David Nutt. “The Entropic Brain: A Theory of Conscious States Informed by Neuroimaging Research with Psychedelic Drugs.” Frontiers in Human Neuroscience 8 (2014): 1–22.
Carhart-Harris, Robin, Leor Roseman, Mark Bolstridge, Lysia Demetriou, J. Nienke Pannekoek, Matthew B. Wall, Mark Tanner, Mendel Kaelen, John McGonigle, Kevin Murphy, Robert Leech, H. Valerie Curran, and David J. Nutt. “Psilocybin for Treatment-Resistant Depression: fMRI-Measured Brain Mechanisms.” Scientific Reports 7 (2017): 1–11.
Carhart-Harris, Robin L., Leor Roseman, Eline Haijen, David Erritzoe, Rosalind Watts, Igor Branchi, and Mendel Kaelen. “Psychedelics and the Essential Importance of Context.” Journal of Psychopharmacology 32 (2018): 725–31.
Carr, E. Summerson. “Enactments of Expertise.” Annual Review of Anthropology 39 (2010): 17–32.
Chapkis, Wendy, and Richard J. Webb. Dying to Get High: Marijuana as Medicine. New York: NYU Press, 2008.
Charmaz, K. Constructing Grounded Theory: A Practical Guide through Qualitative Analysis. London: Sage, 2006.
Cholden, Louis, ed. Proceedings of the Round Table on Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry. New York: Grune & Stratton, 1956.
Christensen, Mark. Acid Christ: Ken Kesey, LSD, and the Politics of Ecstasy. Tucson, Ariz.: Schaffner Press, 2011.
Chwelos, N., Duncan Blewett, Catherine M. Smith, and Abram Hoffer. “Use of d-Lysergic Acid Diethylamide in the Treatment of Alcoholism.” Quarterly Journal of Studies of Alcoholism 20 (1959): 577.
Clark, Walter. “Psychedelic Research: Obstacles and Values.” Journal of Humanistic Psychology 15 (1975): 5–17.
Clarke, Adele, and Joan H. Fujimura. The Right Tools for the Job: At Work in Twentieth-Century Life Science. Princeton, N.J.: Princeton University Press, 1992.
Clarke, Adele, Laura Mamo, Jennifer Ruth Fosket, Jennifer R. Fishman, and Janet K. Shim. Biomedicalization. Durham, N.C.: Duke University Press, 2010.
Cohen, M. “Chromosomal Damage in Human Leukocytes Induced by Lysergic Acid Diethylamide.” Science 155, no. 3768 (1967): 1417–19.
Cohen, Sidney. “A Classification of LSD Complications.” Psychosomatics 7 (1966): 182–86.
Cohen, Sidney. “Lysergic Acid Diethylamide: Side Effects and Complications.” Journal of Nervous and Mental Disease 130 (1960): 30–40.
Cohen, Sidney, and Keith Ditman. “Prolonged Adverse Reactions to Lysergic Acid Diethylamide.” Archives of General Psychiatry 8 (1963): 475–80.
Cole, Jonathan O., and Martin M. Katz. “The Psychotomimetic Drugs: An Overview.” JAMA 187 (1964): 758–61.
Collins, Harry M., and Robert Evans. “Expertise: From Attribute to Attribution and Back Again?” In The Handbook of Science and Technology Studies, edited by Edward J. Hackett, Olga Amsterdamska, Michael Lynch, and Judy Wajcman, 609–30. Cambridge, Mass.: MIT Press, 2007.
Condrau, Gion. “Clinical Experiences in Mental Patients with Lysergic Acid–Diethylamide.” Acta Psychiatry et Neurology 24 (1949): 9.
Conners, Peter. White Hand Society: The Psychedelic Partnership of Timothy Leary and Allen Ginsberg. San Francisco: City Light, 2010.
Craciun, Mariana. “Emotions and Knowledge in Expert Work: A Comparison of Two Psychotherapies.” American Journal of Sociology 12 (2018): 959–1003.
Craciun, Mariana. “Moral Bricolage and Immigrant Identification: The Case of Romanian Americans.” Ethnics and Racial Studies 36 (2011): 729–46.
Crocket, Richard, Ronald A. Sandison, and Alexander Walk, eds. Hallucinogenic Drugs and Their Psychotherapeutic Use. Springfield, Ill.: Charles C. Thomas, 1963.
Dahlberg, Charles C. “LSD: Tamed for Research.” Science, September 30, 1966.
Dahlberg, Charles, Ruth Mechaneck, and Stanley Feldstein. “LSD Research: The Impact of Lay Publicity.” American Journal of Psychiatry 125 (1968): 137–41.
Dass, Ram, and Ralph Metzner. Birth of a Psychedelic Culture: Conversations about Leary, the Harvard Experiments, Millbrook and the Sixties. Santa Fe, N.M.: Synergetic Press, 2010.
Daston, Lorraine, and Peter Galison. Objectivity. Cambridge, Mass.: MIT Press, 2007.
Davidson, B. “The Hidden Evils of LSD.” Saturday Evening Post, August 12, 1967.
DeBold, Richard C., and Russell C. Leaf, eds. LSD, Man, and Society. Middletown, Conn.: Wesleyan University Press, 1967.
Decoteau, Claire, and Paige Sweet. “Psychiatry’s Little Other: DSM-5 and Debates over Psychiatric Science.” Social Theory and Health 14 (2016): 414–35.
Devenot, Neşe. 2018. “Timothy Leary and the Psychodynamics of Stealing Fire.” In Frankenstein and Its Classics: The Modern Prometheus from Antiquity to Science Fiction, edited by Jesse Weiner, Benjamin Eldon Stevens, and Brett M. Rogers, 153–69. New York: Bloomsbury.
Dimascio, A., and G. L. Klerman. “Experimental Human Psychopharmacology: The Role of Non-Drug Factors.” In The Dynamics of Psychiatric Drug Therapy, edited by G. J. Sarwer-Foner, 56–97. Springfield, Ill.: Charles C. Thomas, 1960.
Doblin, Rick. “Dr. Leary’s Concord Prison Experiment: A 34-Year Follow-up Study.” Journal of Psychoactive Drugs 30 (1998): 419–26.
Doblin, Rick. “Pahnke’s ‘Good Friday’ Experiment: A Long-Term Follow-up and Methodological Critique.” Journal of Transpersonal Psychology 23 (1991): 1–28.
Doblin, Rick. Regulation of the Medical Use of Psychedelics and Marijuana. PhD diss., Harvard University, 2000.
Douglas, Mary. Purity and Danger: An Analysis of Concept of Pollution and Taboo. New York: Routledge, 1966.
Dyck, Erika. Psychedelic Psychiatry: LSD from Clinic to Campus. Baltimore, Md.: Johns Hopkins University Press, 2008.
Eagles, Bill. Psychedelic Science. Documentary. BBC, 1997.
Editors. “Hallucinogenic Drugs: The Future.” Lancet 1961: 445.
Editors. “LSD: A Dangerous Drug.” New England Journal of Medicine 273 (1965): 1280.
Edsinger, Eric, and Gul Dolen. “A Conserved Role for Serotonergic Neurotransmission in Mediating Social Behavior in Octopus.” Current Biology 28 (2018): 3136–42.e4.
Eisner, Betty. Remembrances of LSD Therapy Past. Unpublished memoir, 2002.
Eisner, Betty, and Sidney Cohen. “Psychotherapy with Lysergic Acid Diethylamide.” Journal of Nervous and Mental Disease 127 (1958): 528–39.
Eisner, Bruce. Ecstasy: The MDMA Story. Berkeley, Calif.: Ronin, 1993.
Elkes, C., J. Elkes, and W. Mayer-Gross. “Hallucinogenic Drugs.” Lancet 268 (1955): 719.
Ellis, Havelock. “Mescal: A New Artificial Paradise.” Contemporary Review, 1898. https://www.mescaline.com/.
Epstein, Steven. “The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of Clinical Trials.” Science, Technology, and Human Values 20 (1995): 408–37.
Epstein, Steven. Impure Science: AIDS, Activism, and the Politics of Knowledge. Berkeley: University of California Press, 1996.
Epstein, Steven. Inclusion: The Politics of Difference in Medical Research. Chicago: University of Chicago Press, 2007.
Erritzoe, D., L. Roseman, M. M. Nour, K. MacLean, M. Kaelen, D. J. Nutt, and R. L. Carhart-Harris. “Effects of Psilocybin Therapy on Personality Structure.” Acta Psychiatrica Scandinavica 138 (2018): 368–78.
Eyal, Gil, Brendan Hart, Emine Oncular, Neta Oren, and Natasha Rossi. The Autism Matrix: The Social Origins of the Autism Epidemic. Cambridge, Mass.: Polity Press, 2010.
Eyal, Gil. The Disenchantment of the Orient: Expertise in Arab Affairs and the Israeli State. Palo Alto, Calif.: Stanford University Press, 2006.
Eyal, Gil. “For a Sociology of Expertise: The Social Origins of the Autism Epidemic.” American Journal of Sociology 118 (2013): 863–907.
Fadiman, James. The Psychedelic Explorer’s Guide. Rochester, Vt.: Park Street Press, 2011.
Fadiman, James. “Treatment of Alcoholism with Lysergide.” Quarterly Journal of Studies on Alcoholism 28 (1967): 146–47.
Feinstein, Alvan R. “An Additional Basic Science for Clinical Medicine: I. The Limitations of Randomized Trials.” Annals of Internal Medicine 99 (1983): 544–50.
Feld, M., J. Goodman, and J. A. Guido. “Clinical and Laboratory Observations of LSD-25.” Journal of Nervous and Mental Disease 126 (1958): 176–83.
Forte, Robert, ed. Timothy Leary: Outside Looking In. Rochester, Vt.: Park Street Press, 1999.
Foulds, G. A. “Clinical Research in Psychiatry.” Journal of Mental Science 435 (1958): 259–65.
Freedman, D. X. “On the Use and Abuse of LSD.” Archives of General Psychiatry 18 (1968): 330–47.
Frickel, Scott. “Building an Interdiscipline: Collective Action Framing and the Rise of Genetic Toxicology.” Social Problems 51 (2004): 269–87.
Frickel, Scott. “When Convention Becomes Contentious: Organizing Science Activism in Genetic Toxicology.” In The New Political Sociology of Science: Institutions, Networks, and Power, edited by Scott Frickel and Kelly Moore, 185–214. Madison: University of Wisconsin Press, 2006.
Frickel, Scott, and Neil Gross. “A General Theory of Scientific/Intellectual Movements.” American Sociological Review 70 (2005): 204–32.
Frickel, Scott, and Kelly Moore, eds. The New Political Sociology of Science: Institutions, Networks, and Power. Madison: University of Wisconsin Press, 2006.
Frosch, William A., Edwin S. Robbins, and Marvin Stern. “Untoward Reactions to Lysergic Acid Diethylamide Resulting in Hospitalization.” New England Journal of Medicine 273 (1965): 1235–39.
Gamage, James R., and Edmund L. Zerkin, eds. Hallucinogenic Drug Research: Impact on Science and Society: Proceedings of the First Annual Symposium of the Student Association for the Study of Hallucinogens. Beloit, Wisc.: Stash Press, 1970.
Garcia-Romeu, Albert, Roland R. Griffiths, and Matthew W. Johnson. “Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction.” Current Drug Abuse Reviews 7 (2015): 157–64.
Gasser, Peter, Dominique Holstein, Yvonne Michel, Rick Doblin, Berra Yazar-Klosinski, Torsten Passie, and Rudolf Brenneisen. “Safety and Efficacy of Lysergic Acid Diethylamide–Assisted Psychotherapy for Anxiety Associated with Life-threatening Diseases.” Journal of Nervous and Mental Disease 202 (2014): 513–20.
George, Jamilah R., Timothy I. Michaels, Jae Sevelius, and Monnica T. Williams. “The Psychedelic Renaissance and the Limitations of a White-Dominated Medical Framework: A Call for Indigenous and Ethnic Minority Inclusion.” Journal of Psychedelic Studies. In press.
Gerassi, John. Talking with Sartre: Conversations and Debates. New Haven, Conn.: Yale University Press, 2009.
Gieryn, Thomas F. “Boundary-Work and the Demarcation of Science from Non-science: Strains and Interests in Professional Ideologies of Scientists.” American Sociological Review 48 (1983): 81–95.
Glaser, Barney G. The Grounded Theory Perspective: Conceptualization Contrasted with Description. Mill Valley, Calif.: Sociology Press, 2001.
Gordon, Avery. Ghostly Matters: Haunting and the Sociological Imagination. Minneapolis: University of Minnesota Press, 2008.
Gordon, Noah. “The Hallucinogenic Drug Cult.” Reporter, August 15, 1963.
Green, A. Richard. “Gaddum and LSD: The Birth and Growth of Experimental and Clinical Neuropharmacology Research on 5-HT in the U.K.” British Journal of Pharmacology 154 (2008): 1583–99.
Greenfield, Robert. Timothy Leary: A Biography. New York: Mariner Books, 2007.
Greer, George. “Using MDMA in Psychotherapy.” Advances 2 (1985): 57–59.
Griffiths, Roland R., Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards, Brian D. Richards, Mary P. Cosimano, and Margaret A. Klinedinst. “Psilocybin Produces Substantial and Sustained Decreases in Depression and Anxiety in Patients with Life-Threatening Cancer: A Randomized Double-Blind Trial.” Journal of Psychopharmacology 30 (2016): 1181–97.
Griffiths, Roland R., Matthew W. Johnson, William A. Richards, Brian D. Richards, Robert Jesse, Katherine A. MacLean, Frederick S. Barrett, Mary P. Cosimano, and Maggie A. Klinedinst. “Psilocybin-Occasioned Mystical-Type Experience in Combination with Meditation and Other Spiritual Practices Produces Enduring Positive Changes in Psychological Functioning and in Trait Measures of Prosocial Attitudes and Behaviors.” Journal of Psychopharmacology 32 (2018): 49–69.
Griffiths, Roland R., William Richards, Matthew W. Johnson, U. McCann, and Robert Jesse. “Mystical-Type Experiences Occasioned by Psilocybin Mediate the Attribution of Personal Meaning and Spiritual Significance 14 Months Later.” Journal of Psychopharmacology 22 (2008): 21–32.
Griffiths, Roland R., William A. Richards, U. McCann, and Robert Jesse. “Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance.” Psychopharmacology 187 (2006): 268–83.
Grinker, Roy. “Bootlegged Ecstasy.” JAMA 187 (1964): 768.
Grinker, Roy. “Lysergic Acid Diethylamide.” Archives of General Psychiatry 8 (1963): 425.
Grinspoon, Lester, and James Bakalar. Psychedelic Drugs Reconsidered. New York: Basic Books, 1979.
Grob, Charles. “Psychiatric Research with Hallucinogens: What Have We Learned?” Heffter Review of Psychedelic Research 1 (1998): 8–20.
Grob, Charles S., Alicia L. Danforth, Gurpreet S. Chopra, Marycie Hagerty, Charles R. McKay, Adam Halberstadt, and George R. Greer. “Pilot Study of Psilocybin Treatment for Anxiety in Patients with Advanced-Stage Cancer.” Archives of General Psychiatry 68 (2011): 71–78.
Grob, Charles S., and Roger Walsh, eds. Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics. Albany, N.Y.: SUNY Press, 2005.
Grob, Charles, Dennis McHenna, James Callaway, Glacus Brito, Edison Neves, Guilherme Oberlaender, Oswaldo Saide, Elizeu Labigalini, Christiane Tacla, Claudio Miranda, Rick Strassman, and Kyle Boone. “Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil.” Journal of Nervous and Mental Disease 184 (1996): 86–94.
Guttman, Erich. “Artificial Psychoses Produced by Mescaline.” Journal of Mental Science 82 (1936): 203–21.
Haijen, Eline C. H., Mendel Kaelen, Leor Roseman, Christopher Timmermann, Hannes Kettner, Suzanne Russ, David Nutt, Richard E. Daws, Adam D. G. Hampshire, Romy Lorenz, and Robin L. Carthart-Harris. “Predicting Responses to Psychedelics.” Frontiers in Pharmacology 2 (2018): 897.
Halpern, John. “Interview with Dr. John Halpern.” Conducted by Valerie Mojeiko. MAPS Bulletin 11, no. 2 (2001): 10–13.
Halpern, Sydney. Lesser Harms: The Morality of Risk in Medical Research. Chicago: University of Chicago Press, 2004.
Hanna, Jon. “Halperngate.” Entheogen Review 15 (2006): 9–16.
Haraway, Donna J. Modest_Witness@Second_Millennium. FemaleMan_Meets_Onco Mouse: Feminism and Technoscience. New York: Routledge, 1997.
Harman, W. W., R. H. McKim, R. E. Mogar, J. Fadiman, and M. J. Stolaroff. “Psychedelic Agents in Creative Problem-solving: A Pilot Study.” Psychological Reports 19 (1966): 211–27.
Hartogsohn, Ido. “The American Trip: Set, Setting, and Psychedelics in 20th Century Psychology.” MAPS Bulletin 23 (2013): 6–9.
Hartogsohn, Ido. “Constructing Drug Effects: A History of Set and Setting.” Drug Science, Policy and Law 3 (2017): 1–17.
Healy, David. The Creation of Psychopharmacology. Cambridge, Mass.: Harvard University Press, 2004.
Hendricks, Peter, Michael Scott Crawford, Karen L. Cropsey, Heith Copes, N. Wiles Sweat, Zach Walsh, and Gregory Pavela. “The Relationships of Classic Psychedelic Use with Criminal Behavior in the United States Adult Population.” Journal of Psychopharmacology 32 (2017): 37–48.
Hendricks, Peter, Christopher B. Thorne, C. Brendan Clark, David W. Coombs, and Matthew Johnson. “Classic Psychedelic Use Is Associated with Reduced Psychological Distress and Suicidality in the United States Adult Population.” Journal of Psychopharmacology 29 (2015): 280–88.
Herman, Ellen. The Romance of American Psychology: Political Culture in the Age of Experts. Berkeley: University of California Press, 1996.
Herzberg, David. Happy Pills: From Miltown to Prozac. Baltimore, Md.: Johns Hopkins University Press, 2010.
Herzig, Rebecca. Suffering for Science: Reason and Sacrifice in Modern America. New Brunswick, N.J.: Rutgers University Press, 2006.
Hess, David J. “Disciplining Heterodoxy, Circumventing Discipline: Parapsychology, Anthropologically.” In Knowledge and Society, Vol. 9: The Anthropology of Science and Technology, edited by David Hess and Linda Layne, 191–222. Greenwich, Conn.: JAI Press, 1992.
Hicks, Richard E., and Paul Jay Fink, eds. Psychedelic Drugs. New York: Grune & Stratton, 1969.
Higginbotham, Evelyn Brooks. Righteous Discontent: The Women’s Movement in the Black Baptist Church, 1880–1920. Cambridge, Mass.: Harvard University Press, 1994.
Higgs, John. I Have America Surrounded: The Life of Timothy Leary. London: Thistle, 2013.
Hilgartner, Stephen. Science on Stage: Expert Advice as Public Drama. Stanford, Calif.: Stanford University Press, 2000.
Hill, Thomas W. “Peyotism and the Control of Heavy Drinking: The Nebraska Winnebago in the Early 1900s.” Human Organization 49 (1990): 255–65.
Hoch, Paul H. “Experimentally Produced Psychoses.” American Journal of Psychiatry 107 (1951): 607.
Hoch, Paul H., James P. Cattell, and H. Harry. “Effects of Mescaline and Lysergic Acid (d-LSD-25).” American Journal of Psychiatry 108 (1952): 579–84.
Hoffer, Abram, and Humphry Osmond. “Double Blind Clinical Trials.” Journal of Neuropsychiatry 2 (1961): 221–27.
Hoffer, Abram, Humphry Osmond, and John Smythies. “Schizophrenia: A New Approach. II. Result from a Year’s Research.” Journal of Mental Science 100 (1954): 29.
Hofmann, Albert. “History of the Discovery of LSD.” In 50 Years of LSD: Current Status and Perspectives of Hallucinogens, edited by A. Pletscher and D. Ladewig, 7–16. New York: Parthenon, 1994.
Hofmann, Albert. LSD: My Problem Child: Reflections on Sacred Drugs, Mysticism, and Science. Los Angeles, Calif.: J. P. Tarcher, 1980.
Hollister, Leo E., Jack Shelton, and George Krieger. “A Controlled Comparison of Lysergic Acid Diethylamide (LSD) and Dextroamphetamine in Alcoholics.” American Journal of Psychiatry 125 (1969): 1352–57.
Huxley, Aldous. The Doors of Perception (1954) and Heaven and Hell (1956). New York: HarperCollins, 2009.
Huxley, Aldous. Letters of Aldous Huxley. Edited by Grover Smith. New York: Harper & Row, 1969.
Hyde, Robert W. “Psychological and Social Determinants of Drug Action.” In The Dynamics of Psychiatric Drug Therapy, edited by G. J. Sarwer-Foner, 297–312. Springfield, Ill.: Thomas, 1960.
Jangier, Oscar. “The Use of Hallucinogenic Agents in Psychiatry.” California Clinician 55 (1959): 222–24.
Jensen, S. E., and Ronald Ramsay. “Treatment of Chronic Alcoholism with Lysergic Acid Diethylamide.” Canadian Psychiatric Association Journal 8 (1963): 182–87.
Johansen, Pål-Ørjan, and Teri Suzanne Krebs. “Psychedelics Not Linked to Mental Health Problems or Suicidal Behavior: A Population Study.” Journal of Psychopharmacology 29 (2015): 270–79.
Johnson, Matthew, Albert Garcia-Romeu, Mary P. Cosimano, and Roland Griffiths. “Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction.” Journal of Psychopharmacology 28 (2014): 983–92.
Johnson, Matthew W., Roland R. Griffiths, Peter S. Hendricks, and Jack E. Henningfield. “The Abuse Potential of Medical Psilocybin According to the 8 factors of the Controlled Substances Act.” Neuropharmacology 142 (2018): 143–66.
Johnson, Matthew, William Richards, and Roland Griffiths. “Human Hallucinogen Research: Guidelines for Safety.” Journal of Psychopharmacology 22 (2008): 603–20.
Johnson, F. Gordon. “LSD in the Treatment of Alcoholism.” American Journal of Psychiatry 126 (1969): 481–87.
Kaelen, Mendel, Bruna Giribaldi, Jordan Raine, Lisa Evans, Christopher Timmerman, Natalie Rodriguez, Leor Roseman, and Amanda Feilding. “The Hidden Therapist: Evidence for a Central Role of Music in Psychedelic Therapy.” Psychopharmacology 235 (2018): 505–19.
Kaiser, David. How the Hippies Saved Physics. New York: Norton, 2012.
Kempner, Joanna. “The Chilling Effect: How Do Researchers React to Controversy?” PLoS Medicine 5 (2008): 1571–78.
Kempner, Joanna. Not Tonight: Migraine and the Politics of Gender and Health. Chicago: University of Chicago Press, 2014.
Kempner, Joanna, Jon F. Merz, and Charles L. Bosk. “Forbidden Knowledge: Public Controversy and the Production of Nonknowledge.” Sociological Forum 26 (2011): 475–500.
Kepner, Charles H. “Personal Experiences with LSD and Niacin.” Saskatchewan Psychiatric Services Journal 1 (1953): 25–32.
Kleber, Herbert D. “Commentary On: Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance by Griffths et al.” Psychopharmacology 187 (2006): 291–92.
Kluver, H. “Mescal Visions and Eidetic Vision.” American Journal of Psychology 37 (1926): 502.
Knorr-Cetina, Karin. Epistemic Cultures: How the Sciences Make Knowledge. Cambridge, Mass.: Harvard University Press, 1999.
Kolter, Steven. “The New Psychedelic Renaissance.” Playboy, 2011, 114.
Krebs, Terri Suzanne, and Pål-Ørjan Johansen. “Over 30 Million Psychedelic Users in the United States.” F1000Research 2 (2013): 98.
Krebs, Terri Suzanne, and Pål-Ørjan Johansen. “Psychedelics and Mental Health: A Population Study.” PLoS One 8 (2013): 1–9.
Kristeva, Julia. Powers of Horror: An Essay on Abjection. Translated by Leon S. Roudiez. New York: Columbia University Press, 1982.
Kupferschmidt, Kai. “High Hopes.” Science 345, no. 6192 (2014): 18–23.
Kurland, Albert A., Charles Savage, Walter N. Pahnke, Stan Grof, and J. E. Olsson. “LSD in the Treatment of Alcoholics.” Pharmakopsychiat 4 (1971): 83–94.
Lamont, Michele, and Virag Molnar. “The Study of Boundaries in the Social Sciences.” Annual Review of Sociology 28 (2002): 167–95.
Langlitz, Nicolas. Neuropsychedelia: The Revival of Hallucinogen Research since the Decade of the Brain. Berkeley: University of California Press, 2012.
Langner, F. W., and I. Kemp. “LSD.” Quarterly Bulletin of Pinebluff Sanitarium 1 (1956): 368.
Lattin, Don. Distilled Spirits: Getting High, Then Sober, with a Famous Writer, a Forgotten Philosopher, and a Hopeless Drunk. Berkeley: University of California Press, 2012.
Leary, Timothy. Changing My Mind, Among Others. Englewood Cliffs, N.J.: Prentice-Hall, 1982.
Leary, Timothy. Design for Dying. San Francisco, Calif.: Harper Edge, 1997.
Leary, Timothy. “The Effects of Consciousness-Expanding Drugs on Prisoner Rehabilitation.” Psychedelic Review 10 (1969): 20–44.
Leary, Timothy. “The Experiential Typewriter.” Psychedelic Review 7 (1965): 70–85.
Leary, Timothy. “The Religious Experience: Its Production and Interpretation.” In The Psychedelic Reader, edited by Gunther M. Weil, 191–213. New Hyde Park, N.Y.: University Books, 1968.
Leary, Timothy. Flashbacks: A Personal and Cultural History of an Era. Los Angeles, Calif.: Tarcher, 1983.
Leary, Timothy. High Priest. Berkeley, Calif.: Ronin Press, 1968.
Leary, Timothy. “How to Change Behavior.” In LSD: The Consciousness Expanding Drug, edited by David Solomon, 97–113. New York: Putnam, 1964.
Leary, Timothy. The Politics of Ecstasy. Berkeley, Calif.: Ronin, 1970.
Leary, Timothy. Your Brain Is God. Berkeley, Calif.: Ronin, 2001.
Leary, Timothy, and Richard Alpert. “Letter to Crimson by Leary, Alpert.” Harvard Crimson, December 13, 1962. http://www.thecrimson.com/article.aspx?ref=248388.
Leary, Timothy, and Richard Alpert. “The Politics of Consciousness.” Harvard Review 1 (1962): 33–37.
Leary, Timothy, George Litwin, and Ralph Metzner. “Reactions to Psilocybin in a Supportive Environment.” Journal of Nervous and Mental Disease 137 (1963): 561–73.
Leary, Timothy, and Ralph Metzner. “Use of Psychedelic Drugs in Prisoner Rehabilitation.” British Journal of Social Psychiatry 2 (1968): 27–51.
Leary, Timothy, Ralph Metzner, and Richard Alpert. The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead. New York: Kensington, 1964.
Leary, Timothy, Ralph Metzner, Madison Presnell, Gunther Weil, Ralph Schwitzgebel, and Sarah Kinne. “A New Behavior Change Pattern Using Psilocybin.” Psychotherapy: Theory, Research and Practice 2 (1965): 61–72.
Lebedev, Alexander V., Martin Lovden, Gidon Rosenthal, Amanda Feilding, David J. Nutt, and Robin L. Carthart-Harris. “Finding the Self by Losing the Self: Neural Correlates of Ego-Dissolution under Psilocybin.” Human Brain Mapping 36 (2015): 3137–53.
Lebedev, Alexander V., Mendel Kaelen, Martin Lovden, J. Nilsson, Amanda Feilding, David J. Nutt, and Robin Carhart-Harris. “LSD-Induced Entropic Brain Activity Predicts Subsequent Personality Change.” Human Brain Mapping 37 (2016): 3203–13.
Lee, Martin A., and Bruce Shlain. Acid Dreams: The Complete Social History of LSD: The CIA, the Sixties, and Beyond. New York: Grove, 1985.
Lemke-Sanrangelo, Gretchen. Daughters of Aquarius: Women of the Sixties Counter-culture. Lawrence: University Press of Kansas, 2009.
Levine, Jerome, and Arnold Ludwig. “The LSD Controversy.” Comprehensive Psychiatry 5 (1964): 314–21.
Levine, Robert J. Ethics and Regulation of Clinical Research. Baltimore, Md.: Urban & Schwarzenberg, 1986.
Lilienfeld, Abraham M. “Ceteris Paribus: The Evolution of the Clinical Trial.” Bulletin of the History of Medicine 56 (1982): 1–18.
Lin, Geraldine C., and Richard A. Glennon, eds. Hallucinogens: An Update. National Institute on Drug Abuse Research Monograph 146. Rockland, Md.: U.S. Department of Health and Human Services and National Institute on Drug Abuse, 1994. https://archives.drugabuse.gov/sites/default/files/monograph146.pdf.
Ling, Thomas M., and John Buckman. “The Treatment of Frigidity with LSD and Ritalin.” Psychedelic Review 1 (1966): 540–58.
Louria, Donald. “Lysergic Acid Diethylamide.” New England Journal of Medicine 278 (1968): 435–38.
Lowinger, P. “Drug Tests: Integrity and Courage.” Science 53 (1966): 121.
Ludwig, Arnold, Jerome Levine, and Louis H. Stark. LSD and Alcoholism: A Clinical Study of Treatment Efficacy. Springfield, Ill.: Charles Thomas, 1970.
Ludwig, Arnold, Jerome Levine, Louis Stark, and Robert Lazar. “A Clinical Study of LSD Treatment in Alcoholism.” American Journal of Psychiatry 126 (1969): 59–69.
Lyons, Taylor, and Robin L. Carhart-Harris. “Increased Nature Relatedness and Decreased Authoritarian Political Views after Psilocybin for Treatment-Resistant Depression.” Journal of Psychopharmacology 32 (2018): 811–19.
MacLean, L. R., D. C. MacDonald, U. P. Byrne, and A. M. Hubbard. “The Use of LSD-25 in the Treatment of Alcoholism and Other Psychiatric Problems.” Quarterly Journal of Studies on Alcohol 22 (1962): 34–45.
MacLean, J. Ross, and W. E. Wilby. “Treatment of Alcoholism with Lysergide: Comment on the Article by Smart et al. with Special Reference to Issues of Responsibility in Research Reporting.” Quarterly Journal of Studies on Alcohol 28 (1967): 140–46.
MacLean, Katherine A., Matthew W. Johnson, and Roland R. Griffiths. “Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness.” Journal of Psychopharmacology 25 (2011): 1453–61.
MacLean, Katherine A., Jeannie-Marrie S. Leoutsakos, Matthew W. Johnson, and Roland R. Griffiths. “Factor Analysis of the Mystical Experience Questionnaire.” Journal for the Scientific Study of Religion 51 (2012): 721–37.
Malone, Tara C., Sarah E. Mennenga, Jeffrey Guss, Samantha K. Podrebarac, Lindsey T. Owens, Anthony P. Bossis, Alexander B. Belser, Gabrielle Agin-Liebes, Michael P. Bogenschutz, and Stephen Ross. “Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.” Frontiers in Pharmacology 9 (2018): 256.
Mangini, Mariavittoria. “Treatment of Alcoholism Using Psychedelic Drugs: A Review of the Program of Research.” Journal of Psychoactive Drugs 30 (1998): 381–418.
Marks, Harry M. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990. Cambridge: Cambridge University Press, 2000.
Metzel, Johnathan. Prozac on the Couch: Prescribing Gender in the Era of Wonder Drugs. Durham, N.C.: Duke University Press, 2003.
Metzner, R., G. Litwin, and G. M. Weil. “The Relation of Expectation and Mood to Psilocybin Reactions: A Questionnaire Study.” Psychedelic Review 5 (1966): 3–39.
Metzner, Ralph, and Timothy Leary. “On Programming Psychedelic Experiences.” Psychedelic Review 9 (1967): 5–19.
Meyer, Roger E., ed. Adverse Reactions to Hallucinogenic Drugs: Conference Held at the National Institute of Mental Health. Washington, D.C.: U.S. Government Printing Office, 1969.
Michaels, Timothy I., Jennifer Purdon, Alexis Collins, and Monnica T. Williams. “Inclusion of People of Color in Psychedelic-Assisted Psychotherapy: A Review of the Literature.” BMC Psychiatry 18 (2018): 245.
Mitchell, Silas Weir. “Remarks in the Effects of Anhelonium lewinii (the Mescal Button).” British Medical Journal 2 (1896): 1625–29.
Mithoefer, Michael C., Ann T. Mithoefer, Allison A. Feduccia, Lisa Jerome, Mark Wagner, Joy Wymer, Julie Holland, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, and Rick Doblin. “3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy for Post-traumatic Stress Disorder in Military Veterans, Firefighters, and Police Officers: A Randomised, Double-Blind, Dose-Response, Phase 2 Clinical Trial.” Lancet Psychiatry 5 (2018): 486–87.
Mithoefer, Michael, Mark T. Wagner, Ann T. Mithoefer, Lisa Jerome, and Rick Doblin. “The Safety and Efficacy of ±3,4-Methylenedioxymethamphetamine-Assisted Psychotherapy in Subjects with Chronic, Treatment-Resistant Posttraumatic Stress Disorder: The First Randomized Controlled Pilot Study.” Journal of Psychophamacology 25 (2011): 439–52.
Mogar, Robert E. “Research in Psychedelic Drug Therapy: A Critical Analysis.” In Research in Psychotherapy, edited by John M. Shlien, 500–511. Washington, D.C.: American Psychological Association, 1968.
Mogar, Robert E., and Charles Savage. “Personality Change Associated with Psychedelic (LSD) Therapy: A Preliminary Report.” Psychotherapy 1 (1964): 154–62.
Montgomery, Catherine M. “From Standardization to Adaptation: Clinical Trials and the Moral Economy of Anticipation.” Science as Culture 26 (2016): 1–23.
Moore, Kelly. Disrupting Science: Social Movements, American Scientists, and the Politics of the Military, 1945–1975. Princeton, N.J.: Princeton University Press, 2013.
Moreno, Francisco A., Christopher B. Wiegand, E. Keolani Taitano, and Pedro L. Delgado. “Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients with Obsessive-Compulsive Disorder.” Journal of Clinical Psychiatry 67 (2006): 1735–40.
Murphy, Michelle. “Immodest Witnessing: The Epistemology of Vaginal Self-Examination in the U.S. Feminist Self-Help Movement.” Feminist Studies 30 (2004): 115–47.
Nichols, David E. “Hallucinogens.” Pharmacology and Therapeutics 101 (2004): 131–81.
Nichols, David E. “The Heffter Research Institute: Past and Hopeful Future.” Journal of Psychoactive Drugs 46 (2014): 20–26.
Nielson, Elizabeth, and Jeffrey Guss. “The Influence of Therapists’ First-Hand Experience with Psychedelics on Psychedelic-Assisted Psychotherapy Research and Therapist Training.” Journal of Psychedelic Studies 2 (2018): 64–73.
Nour, Matthew M., Lisa Evans, David Nutt, and Robin L. Carhart-Harris. “Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory.” Frontiers in Human Neuroscience 10 (2016): 1–13.
Novak, Steven J. “LSD before Leary: Sidney Cohen’s Critique of 1950s Psychedelic Drug Research.” Isis 88 (1997): 87–110.
Nutt, David J., Leslie A. King, and David E. Nichols. “Effects of Schedule I Drug Laws on Neuroscience Research and Treatment Innovation.” Nature Reviews Neuroscience 14 (2013): 577–85.
Nutt, David J., Leslie A. King, and Lawrence D. Phillips. “Drug Harms in the U.K.: A Multicriteria Decision Analysis.” Lancet 376, no. 9752 (2010): 1558–65.
Nutt, David J., Leslie A. King, William Saulsbury, and Colin Blakemore. “Development of a Rational Scale to Access the Harm of Drugs Potential Misuse.” Lancet 369, no. 9566 (2007): 1047–53.
Oram, Matthew. “Efficacy and Enlightenment: LSD Psychotherapy and the Drug Amendments of 1962.” Journal of the History of Medicine and Allied Sciences 69 (2012): 221–50.
Oram, Matthew. The Trials of Psychedelic Therapy. Baltimore, Md.: Johns Hopkins University Press, 2018.
Osmond, Humphrey. “Methodology: Handmaiden or Taskmistress?” Canadian Medical Association Journal 87 (1962): 707–8.
Osmond, Humphry. “On Being Mad.” Saskatchewan Psychiatric Services Journal 1 (1952): 63–70.
Osmond, Humphry. “Peyote Night.” Tomorrow Magazine, 1961. http://www.psychedelic-library.org/peyote.htm.
Osmond, Humphry. “A Review of the Clinical Effects of Psychotomimetic Agents.” Annals of the New York Academy of Sciences 66 (1957): 418–34.
Osmond, Humphry, and John K. Smythies. “Schizophrenia: A New Approach.” Journal of Mental Science 98 (1952): 309.
Pahnke, Walter N. “Drugs and Mysticism.” In Psychedelics: The Uses and Implications of Hallucinogenic Drugs, edited by Bernard Aaronson and Humphrey Osmond, 145–64. Garden City, N.J.: Anchor Books, 1970.
Pahnke, Walter N., Albert A. Kurland, Louis E. Goodman, and William A. Richards. “LSD-Assisted Psychotherapy with Terminal Cancer Patients.” Current Psychiatric Therapies 9 (1969): 144–52.
Pekkanen, Sarah. “U.S. May Lift ‘Ban’ on LSD Testing.” San Francisco Examiner, July 27, 1992.
Pinch, Trevor J., and Wiebe E. Bijker. “The Social Construction of Facts and Artefacts, or How the Sociology of Science and the Sociology of Technology might Benefit Each Other.” Social Studies of Science 14 (1984): 399–441.
“Playboy Interview: Timothy Leary.” Playboy Magazine, 1966.
Pletscher, A., and D. Ladewig, eds. 50 Years of LSD: Current Status and Perspectives of Hallucinogens. New York: Parthenon, 1994.
Pollan, Michael. How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence. New York: Penguin, 2018.
Pollard, John C. “Shrouds around LSD.” Science 154 (1966): 844.
Porter, Theodore M. Trust in Numbers: The Pursuit of Objectivity in Science and Public Life. Princeton, N.J.: Princeton University Press, 1996.
Reinarman, Craig. “The Social Construction of Drug Scares.” In Constructions of Deviance: Social Power, Context, and Interaction, edited by Patricia A. Adler and Peter Adler, 54–61. Belmont, Calif.: Wadsworth, 1994.
Research Task Force. Research in the Service of Mental Health: Summary Report of the Research Task Force of the National Institute of Mental Health. Rockville, Md.: National Institute of Mental Health, 1975.
Rinkel, Max. “Psychedelic Drugs.” American Journal of Psychiatry 122 (1966): 1415–16.
Rinkel, Max, H. DeShon, R. Hyde, and H. Solomon. “Experimental Schizophrenia-Like Symptoms.” American Journal of Psychiatry 108 (1952): 572–78.
Rolo, A., L. W. Krinsky, and L. Goldfarb. “LSD as an Adjunct to Psychotherapy with Alcoholics.” Journal of Psychology 50 (1960): 85–104.
Roseman, Leor, Lysia Demetrios, Matthew B. Wall, David J. Nutt, and Robin L. Carthart-Harris. “Increased Amygdala Responses to Emotional Faces after Psilocybin for Treatment-Resistant Depression.” Neuropharmacology 142 (2018): 263–69.
Rosin, Carol, and Vicki Marshall. “On Leary and Drugs at the End.” MAPS Bulletin 6 (1996): 13–16.
Ross, Stephen., Anthony Bossis, Jeffrey Guss, Gabrielle Agin-Liebes, Tara Malone, Barry Cohen, Sarah E. Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb, Zhe Su, Patricia Corby, and Brian L. Schmidt. “Rapid and Sustained Symptom Reduction Following Psilocybin Treatment for Anxiety and Depression in Patients with Life-Threatening Cancer: A Randomized Controlled Trial.” Journal of Psychopharmacology 30 (2016): 1165–80.
Rothlin, E. “Lysergic Acid Diethylamide and Related Substances.” Annuals of the New York Academy of Sciences 66 (1957): 668–76.
Sandison, R. A., A. M. Spencer, and J. D. A. Whitelaw. “The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness.” Journal of Mental Science 100 (1954): 491–507.
Savage, Charles. “LSD, Alcoholism, and Transcendence.” Journal of Nervous and Mental Disease 135 (1962): 429–35.
Savage, Charles, Ethel Savage, James Fadiman, and Willis Harman. “LSD: Therapeutic Effects of the Psychedelic Experience.” Psychological Reports 14 (1964): 111–20.
Savage, Charles, and O. Lee McCabe. “Residential Psychedelic (LSD) Therapy for the Narcotic Addict: A Controlled Study.” Archives of General Psychiatry 28 (1973): 808.
Schultes, Richard Evans, Albert Hofmann, and Christian Ratsch. Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers. Rochester, Vt.: Healing Arts Press, 1992.
Schuster, Charles R. “Commentary On: Psilocybin Can Occasion Mystical-Type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance by Griffths et al.” Psychopharmacology 187 (2006): 289–90.
Sessa, Ben. “Author’s Reply: Can Psychedelics Have a Role in Psychiatry Once Again?” British Journal of Psychiatry 187 (2005): 484–85.
Sessa, Ben. The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society. London: Muswell Hill Press, 2013.
Sessa, Ben. “Turn On and Tune In to Evidence-Based Psychedelic Research” (comment). Lancet Psychiatry 2 (2015): 10–12.
Sessa, Ben. “Update from the U.K. and an Interview with Pioneering Psychedelic Psychiatrist Dr. Ronald Sandison.” MAPS Bulletin 18 (2008): 32–35.
Sewell, R. Andrew. “So You Want to be a Psychedelic Researcher?” MAPS Bulletin 16, no. 2 (2005): 20–25.
Shapin, Steven. “Cordelia’s Love: Credibility and the Social Studies of Science.” Perspectives on Science 3 (1995): 255–75.
Shapin, Steven. Never Pure. Baltimore, Md.: Johns Hopkins University Press, 2010.
Shapin, Steven, and Simon Schaffer. Leviathan and the Air-Pump: Hobbes, Boyle, and the Experimental Life. Princeton, N.J.: Princeton University Press, 1985.
Sherwood, J. N., Myron Stolaroff, and Willis Harman. “The Psychedelic Experience: A New Concept in Psychotherapy.” Journal of Neuropsychiatry 4 (1962): 69–80.
Shroder, Tom. Acid Test: LSD, Ecstasy, and the Power to Heal. London: Penguin Random House, 2015.
Siff, Stephen. Acid Hype: American News Media and the Psychedelic Experience. Champaign: University of Illinois Press, 2015.
Smart, Reginald G., and Thomas Storm. “The Efficacy of LSD in the Treatment of Alcoholism.” Quarterly Journal of Studies of Alcoholism 25 (1964): 333–38.
Smart, Reginald G., Thomas Storm, Earle F. W. Baker, and Lionel Solursh. “A Controlled Study of Lysergide in the Treatment of Alcoholism.” Quarterly Journal of Studies on Alcohol 27 (1966): 469–82.
Smith, Colin M. “A New Adjunct to the Treatment of Alcoholism: The Hallucinogenic Drugs.” Quarterly Journal of Studies of Alcoholism 19 (1958): 406–17.
Smith, Colin M. “Some Reflections on the Possible Therapeutic Effects of the Hallucinogens with Special Reference to Alcoholism.” Quarterly Journal of Studies of Alcoholism 20 (1959): 292–301.
Snelders, Stephen, and Charles Kaplan. “LSD Therapy in Dutch Psychiatry: Changing Socio-political Settings and Medical Sets.” Medical History 46 (2002): 221–40.
Snelders, Stephen, Charles Kaplan, and Toine Pieters. “On Cannabis, Chloral Hydrate, and Career Cycles of Psychotropic Drugs in Medicine.” Bulletin of the History of Medicine 80 (2006): 95–114.
Snyder, William U. “Psychotherapy.” In Annual Review of Psychology, edited by P. R. Farnsworth and Q. McNemar, 353–74. Palo Alto, Calif.: Annual Reviews, 1958.
Stafford, P. G., and B. H. Golightly. LSD: The Problem-Solving Psychedelic. New York: Award Books, 1967.
Stampnitzky, Lisa. “Disciplining an Unruly Field: Terrorism Experts and Theories of Scientific/Intellectual Production.” Qualitative Sociology 34 (2010): 1–19.
Starr, Paul. The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry. New York: Basic Books, 1982.
Stevens, Jay. Storming Heaven: LSD and the American Dream. New York: Grove, 1987.
Stolaroff, Myron J. Thanatos to Eros: 35 Years of Psychedelic Exploration. Berlin: Verlag für Wissenschaft und Bildung, 1994.
Stolaroff, Myron J. The Secret Chief Revealed. Sarasota, Fla.: Multidisciplinary Association for Psychedelic Studies (MAPS), 2004.
Stoll, Werner A. “Lysergsaüre-diäthyl-amid, ein Phantastikum aus der Mutterkorngruppe.” Schweizer Archiv für Neurologie und Psychiatrie 60 (1947): 279–323.
Strassman, Rick. DMT: The Spirit Molecule. Rochester, Vt.: Park Street Press, 2001.
Strassman, Rick. “Human Hallucinogenic Drug Research in the United States: A Present-Day Case History and Review of the Process.” Journal of Psychoactive Drugs 23 (1991): 29–38.
Strassman, Rick. “Hallucinogen Drugs in Psychiatric Research and Treatment: Perspectives and Prospects.” Journal of Nervous and Mental Disease 183 (1995): 127–38.
Strassman, Rick. “Human Psychopharmacology of N,N-Dimethyltryptamine.” Behavioural Brain Research 73 (1996): 121–24.
Strassman, Rick. “The Psychedelic Religion of Mystical Consciousness.” Journal of Psychedelic Studies 2 (2018): 1–4.
Strassman, Rick J., Clifford R. Qualls, and Laura M. Berg. “Differential Tolerance to Biological and Subjective Effects of Four Closely Spaced Doses of N,N-Dimethyltryptamine in Humans.” Biological Psychiatry 39 (1996): 784–95.
Strassman, Rick J., Clifford R. Qualls, Eberhard H. Uhlenhuth, and Robert Kellner. “Dose–Response Study of N,N-Dimethyltryptamine in Humans.” Archives of General Psychiatry 51 (1994): 98–108.
Subcommittee of the Committee on the Judiciary. The Narcotic Rehabilitation Act of 1966. Washington, D.C.: U.S. Government Printing Office, 1966.
Subcommittee on Executive Reorganization of the Committee on Government Operations. Organization and Coordination of Federal Drug Research and Regulatory Programs: LSD. Washington, D.C.: U.S. Government Printing Office, 1966.
Sweet, Paige, and Danielle Giffort. “The Bad Expert: Turning Points in Expertise Cultures.” Unpublished manuscript.
Swift, Thomas C., B. Alexander Belser, Gabrielle Agin-Liebes, Neşe Devenot, Sara Terrana, Harris L. Friedman, Jeffrey Guss, Anthony Bossis, and Stephen Ross. “Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress.” Journal of Humanistic Psychology 57 (2017): 488–519.
Swindler, Ann. “Culture in Action: Symbols and Strategies.” American Sociological Review 51 (1986): 273–86.
Taylor, Verta. “Social Movement Continuity: The Women’s Movement in Abeyance.” American Sociological Review 54 (1989): 761–75.
Tenenbaum, Bertrand. “Group Therapy with LSD-25.” Diseases of the Nervous System 22 (1961): 459–62.
Thiessen, Michelle S., Zach Walsh, Brian M. Bird, and Adele Lafrance. “Psychedelic Use and Intimate Partner Violence.” Journal of Psychopharmacology 32 (2018): 749–55.
Timmermans, Stefan, and Hyeyoung Oh. “The Continued Social Transformation of the Medical Profession.” Journal of Health and Social Behavior 1 (2010): S94–106.
Tjio, Joe Hin, Walter N. Pahnke, and Albert A. Kurland. “LSD and Chromosomes.” Journal of the American Medical Association 210 (1969): 849–56.
Toumey, Christopher P. “The Moral Character of Mad Scientists: A Cultural Critique of Science.” Science, Technology, and Human Values 17 (1992): 411–37.
Ulea, Anca. “Psychedelics 2.0 and the Shadow of the Sixties.” Psychology Today, February 4, 2014. https://www.psychologytoday.com/.
Underman, Kelly, and Laura E. Hirshfield. “Detached Concern? Emotional Socialization in Twenty-First Century Medical Education.” Social Science and Medicine 160 (2016): 94–101.
Ungerleider, J. Thomas, ed. The Problems and Prospects of LSD. Springfield, Ill.: Charles C. Thomas, 1968.
Ungerleider, J. Thomas, and Duke D. Fisher. “The Problems of LSD and Emotional Disorder.” California Medicine 106 (1967): 49–55.
Von Felsinger, John M., Louis Lasagna, and Henry K. Beecher. “The Response of Normal Men to Lysergic Acid Derivatives (Di- and Mono-Ethyl Amides).” Journal of Clinical and Experimental Psychopathology 17 (1956): 414–28.
Wade, Simeon. Foucault in California. Berkeley, Calif.: Heyday, 2019.
Watts, Rosalind, Camilla Day, Jacob Krzanowski, David Nutt, and Robin Carhart-Harris. “Patients’ Accounts of Increased ‘Connectedness’ and ‘Acceptance’ after Psilocybin for Treatment-Resistant Depression.” Journal of Humanistic Psychology 57 (2017): 520–64.
Weil, Andrew T. “The Strange Case of the Harvard Drug Scandal.” Look Magazine, November 5, 1963.
Winkler, Petr, and Ladislav Csémy. “Self-Experimentations with Psychedelics among Mental Health Professionals: LSD in the Former Czechoslovakia.” Journal of Psychoactive Drugs 46 (2014): 11–19.
Wolfe, Alan. “Public and Private in Theory and Practice: Some Implications of an Uncertain Boundary.” In Public and Private in Thought and Practice: Perspectives on a Grand Dichotomy, edited by Jeff Weintraub and Krishan Kumar, 182–203. Chicago: University of Chicago Press, 1997.
World Health Organization. Ataractic and Hallucinogenic Drugs in Psychiatry: Report of a Study Group. Geneva: World Health Organization, 1958. https://apps.who.int/iris/handle/10665/40410?show=full.
Yensen, Richard, and Donna Dryer. “Thirty Years of Psychedelic Research: The Spring Grove Experiment and Its Sequels.” In Jahrbuch des Europäischen Collegiums für Bewusstseinsstudien/Yearbook of the European College for the Study of Consciousness. Berlin: VWB—Verlag für Wissenschaft und Bildung Amand Aglaster, 1992.